Ignite Creation Date:
2024-05-05 @ 11:28 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00055562
Status:
COMPLETED
Last Update Posted:
2005-06-24
First Post:
2003-03-05
Brief Title:
Study to Compare the Efficacy and Safety of Two CC-5013 Dose Regimens in Subjects With Metastatic Malignant Melanoma
Sponsor:
Celgene Corporation
Organization:
Celgene